Azupedia

Translations:SGLT2 inhibitor/43/ja: Revision history

View logs for this page (view abuse log)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 February 2024

  • curprev 09:1709:17, 13 February 2024 Fire talk contribs 1,828 bytes +1,828 Created page with "==外部リンク== * {{cite web | title=FDA revises label of diabetes drug canagliflozin | website=U.S. Food and Drug Administration | date=15 January 2016 | url=https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-revises-label-diabetes-drug-canagliflozin-invokana-invokamet }} * {{cite web | title=FDA Drug Safety Communication: FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana,..."
Retrieved from "https://wiki.tiffa.net/wiki/Translations:SGLT2_inhibitor/43/ja"